Compare CDXS & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDXS | ACR |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 134.4M |
| IPO Year | 2008 | N/A |
| Metric | CDXS | ACR |
|---|---|---|
| Price | $1.12 | $18.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $24.50 |
| AVG Volume (30 Days) | ★ 1.3M | 22.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.54 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $15.64 | $3.67 |
| Revenue Next Year | $5.23 | $1.87 |
| P/E Ratio | ★ N/A | $19.59 |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $1.05 | $16.51 |
| 52 Week High | $4.30 | $24.61 |
| Indicator | CDXS | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 33.75 | 39.12 |
| Support Level | N/A | $17.45 |
| Resistance Level | $2.56 | $19.50 |
| Average True Range (ATR) | 0.08 | 0.54 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 16.18 | 50.54 |
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.